Together we will beat cancer

Donate

Could measles cure cancer? Uh, not exactly…

Media outlets are awash with the news that researchers in the US have apparently cured cancer with the measles virus. What are the facts behind the headlines?

Read More

Notes from NCRI conference (day 4)

Before the final day of the conference started, we once again awoke to news stories based on research presented over…

Read More

Introducing our new Clinician Scientist Fellows

Translating a ‘eureka’ moment in the laboratory into new medical advances for cancer patients is never easy. But thanks to…

Read More

Misleading reporting of the “wonder jab that will kill 90% of cancers”

Over the weekend you may have seen headlines announcing that a “‘Universal’ cancer vaccine” or “wonder jab” has been developed…

Read More

Scientists identify first genetic link to myeloma

For the first time researchers have identified genetic variations that influence a person’s chances of developing a type of blood cancer called multiple myeloma, according to a British study part-funded by Cancer Research UK.

Read More

Is ecstasy ‘being developed to treat blood cancers’? Not quite…

Here are a few thoughts on this morning’s headlines about ecstasy and cancer. (In case you missed them, they’re based…

Read More

Making research count for patients – the multiple myeloma story

This year at the ASCO conference in the US, several sessions reflected on the rapid progress that has been made…

Read More

NICE recommends bortezomib and thalidomide for multiple myeloma

NICE has released guidance which recommends the drugs bortezomib and thalidomide as therapies for some patients with multiple myeloma.

Read More

Protein regulates tumour cell growth in multiple myeloma

A protein known to be linked to inflammation may play an important role in the progression of some human cancers, scientists have revealed.

Read More

Proof that controversial therapy is effective

Cancer Research UK scientists have for the first time shown that a controversial treatment is more effective than traditional chemotherapy for treating multiple myeloma, a cancer of the bone marrow.

Read More